Hot Features
Premium
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Period:
Draw Mode:
| Volume | 22,619 |
|
|||||
| News | - | ||||||
| Day High | 8.82 | Low High |
|||||
| Day Low | 8.50 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Benitec Biopharma Limited | BNTC | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.2785 | 3.30% | 8.7285 | 11:15:42 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 8.64 | 8.50 | 8.82 | 8.45 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 203 | 22,619 | US$ 8.66 | US$ 195,867 | - | 1.86 - 9.01 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 11:17:17 | 1 | US$ 8.6745 | USD |
Benitec Biopharma Limited Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| US$ 22.63M | - | - | - | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Benitec Biopharma News
| Date | Time | Source | News Article |
|---|---|---|---|
| 3/08/2024 | 15:17 | Edgar (US Regulatory) | Form 8-K - Current report |
| 3/08/2024 | 15:13 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
| 3/08/2024 | 15:12 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
| 3/05/2024 | 23:15 | Edgar (US Regulatory) | Form EFFECT - Notice of Effectiveness |
| 2/26/2024 | 08:06 | Edgar (US Regulatory) | Form DEL AM - Delaying amendment |
| 2/23/2024 | 15:09 | Edgar (US Regulatory) | Form S-3 - Registration statement under Securities Act of.. |
| 2/13/2024 | 07:15 | Edgar (US Regulatory) | Form 8-K - Current report |
| 2/13/2024 | 07:01 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
| 12/07/2023 | 15:15 | Edgar (US Regulatory) | Form 8-K - Current report |
| 11/30/2023 | 06:31 | Edgar (US Regulatory) | Form 8-K - Current report |
| 11/17/2023 | 07:00 | GlobeNewswire Inc. | Benitec Biopharma to Participate in a Fireside Chat at the.. |
| 11/13/2023 | 07:03 | Edgar (US Regulatory) | Form 8-K - Current report |
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical BNTC Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 6.96 | 8.82 | 6.48 | 7.50 | 45,203 | 1.77 | 25.41% |
| 1 Month | 5.20 | 8.82 | 4.75 | 6.78 | 221,380 | 3.53 | 67.86% |
| 3 Months | 3.09 | 8.82 | 2.70 | 6.45 | 89,498 | 5.64 | 182.48% |
| 6 Months | 3.62 | 8.82 | 2.69 | 6.13 | 46,497 | 5.11 | 141.12% |
| 1 Year | 3.3082 | 9.01 | 1.86 | 5.43 | 1,047,575 | 5.42 | 163.84% |
| 3 Years | 72.59 | 99.62 | 1.86 | 13.83 | 680,083 | -63.86 | -87.98% |
| 5 Years | 32.3017 | 295.6198 | 1.86 | 46.31 | 588,999 | -23.57 | -72.98% |
Benitec Biopharma Description
| Benitec Biopharma Inc is a biotechnology company developing a proprietary therapeutic technology platform that combines RNA interference with gene therapy for providing sustained, long-lasting silencing of disease-causing genes from a single administration. Its technology has the potential to provide a one-shot cure for a wide range of diseases that are addressed by strict ongoing treatment regimens or that have no effective treatment or only palliative care options. The company is developing product candidates in chronic and life-threatening human disease areas including Orphan disease: Oculopharyngeal Muscular Dystrophy (OPMD) and Infectious disease: Hepatitis B Virus (HBV). |
